Related Experiment Video
Updated: Jul 19, 2026
07:45
"Sun's Seven-Step Technique" for Endoscopic En-Bloc Resection of Thyroid Cancer via the Chest-Breast Approach
Published on: November 28, 2025
Laryngeal cancer after topical mitomycin C application.
1Department of Otolaryngology, Guy's and St Thomas'/Evelina Children's Hospital, London, UK. namitagrawal@yahoo.com
The Journal of Laryngology and Otology
|October 17, 2006
Summary
Topical mitomycin C, used for scar prevention, may increase cancer risk. This report details the first known case of laryngeal carcinoma potentially induced by mitomycin C in a non-smoking adult.
Area of Science:
- Oncology
- Pharmacology
- Laryngology
Background:
- Mitomycin C is an antibiotic used in cancer treatment and topically for scar prevention in the larynx.
- It is an alkylating agent with known carcinogenic potential.
Observation:
- A non-smoking adult developed laryngeal carcinoma after topical mitomycin C application for a glottic web.
- This is the first reported case in the world literature.
Findings:
- Topical mitomycin C application may be associated with the development of laryngeal carcinoma.
- The mechanism involves its action as an alkylating agent.
Implications:
- Caution is advised when using topical mitomycin C for benign laryngeal conditions.
- Further research is needed to understand the long-term risks and optimal use of mitomycin C.